# Relationships Among FVIII, t-PA/PAI-1, and MMP-9 Levels and Intracranial Hemorrhage Complications After Thrombolysis With Alteplase in Patients With Acute Ischemic Stroke: Protocol for a Multicenter Retrospective Study

> **NCT03733223** · — · UNKNOWN · sponsor: **Zhujiang Hospital** · enrollment: 350 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Ateptidase

## Key facts

- **NCT ID:** NCT03733223
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-12
- **Primary completion:** 2020-06
- **Final completion:** 2020-12
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2019-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03733223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03733223, "Relationships Among FVIII, t-PA/PAI-1, and MMP-9 Levels and Intracranial Hemorrhage Complications After Thrombolysis With Alteplase in Patients With Acute Ischemic Stroke: Protocol for a Multicenter Retrospective Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03733223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*